PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22722256-0	2013	Inhibition of pancreatic cancer cell growth in vivo using a tetracycline-inducible cyclin D1 antisense expression system.	Tetracycline	60-72	cyclin D1	Homo sapiens	83-92	
22722256-5	2013	RESULTS: In vitro removal of tetracycline induced cyclin D1 antisense cDNA expression and inhibited cyclin D1 expression and cyclin D1-associated kinase activity as well as anchorage-dependent and -independent growth.	Tetracycline	29-41	cyclin D1	Homo sapiens	50-59	
22722256-5	2013	RESULTS: In vitro removal of tetracycline induced cyclin D1 antisense cDNA expression and inhibited cyclin D1 expression and cyclin D1-associated kinase activity as well as anchorage-dependent and -independent growth.	Tetracycline	29-41	cyclin D1	Homo sapiens	100-109	
22722256-5	2013	RESULTS: In vitro removal of tetracycline induced cyclin D1 antisense cDNA expression and inhibited cyclin D1 expression and cyclin D1-associated kinase activity as well as anchorage-dependent and -independent growth.	Tetracycline	29-41	cyclin D1	Homo sapiens	100-109	
16927018-8	2006	However, introduced cyclin D1 into Jurkat T tetracycline (Tet)-On cell system still couldn"t rescue cells from apoptosis.	Tetracycline	58-61	cyclin D1	Homo sapiens	20-29	
18665077-4	2008	METHODS: Parental cells, cells overexpressing FGFR1-III isoforms, and cells harboring a tetracycline-inducible cyclin D1 antisense expression vector system were used as model systems.	Tetracycline	88-100	cyclin D1	Homo sapiens	111-120	
15111320-6	2004	The Ishikawa cell line, with stable or tetracycline-regulated expression of mutant beta-catenin, showed an increase in expression levels of cyclin D1, p14ARF, p53, and p21WAF1 but not PML, and activation of beta-catenin-TCF4-mediated transcription determined with TOP/FOP constructs.	Tetracycline	39-51	cyclin D1	Homo sapiens	140-149	
15289334-5	2004	We demonstrate here that in EJ human bladder cancer cells containing a tetracycline-regulatable s-HB-EGF or pro-HB-EGF expression system, s-HB-EGF expression increased their transformed phenotypes, including growth rate, colony-forming ability, and activation of cyclin D1 promoter, as well as induction of vascular endothelial growth factor in vitro.	Tetracycline	71-83	cyclin D1	Homo sapiens	263-272	
9692552-6	1998	RIE-1 cells were engineered to overexpress human cyclin D1 under the control of a tetracycline-repressible promoter.	Tetracycline	82-94	cyclin D1	Homo sapiens	49-58	
10070974-4	1999	MCF7 cells cultured without tetracycline resulted in a 6-fold increase in the cyclin D1 protein.	Tetracycline	28-40	cyclin D1	Homo sapiens	78-87	
9692552-7	1998	These cells entered S phase in the presence of TGF-beta1 only when human cyclin D1 was derepressed by the withdrawal of tetracycline.	Tetracycline	120-132	cyclin D1	Homo sapiens	73-82	
9191053-2	1997	To address the relationship between cyclin D1 and other cell cycle regulatory proteins, we established human glioma and rodent fibroblast cell lines in which cyclin D1 expression could be regulated ectopically with tetracycline.	Tetracycline	215-227	cyclin D1	Homo sapiens	158-167